Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Bibliographic Details
Main Authors:	J Hugosson, MJ Roobol, M Månsson, TLJ Tammela, M Zappa, V Nelen, Felipe Lott
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2020-03-01
Series:	International Brazilian Journal of Urology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382020000300465&tlng=en

Similar Items

Screening and prostate-cancer mortality in a randomized European study.
by: Schröder, F, et al.
Published: (2009)

Test sensitivity in the European prostate cancer screening trial: results from Finland, Sweden, and the Netherlands.
by: Auvinen, A, et al.
Published: (2009)

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
by: Roobol, M, et al.
Published: (2009)

Prostate-cancer mortality at 11 years of follow-up.
by: Schröder, F, et al.
Published: (2012)

Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer
by: Rebecka Arnsrud Godtman, et al.
Published: (2021-12-01)

Prostate cancer screening in the elderly: A yes or no issue? Long term follow-up data from ERSPC Rotterdam
by: M.J. Roobol, et al.
Published: (2020-07-01)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
by: Bangma, C, et al.
Published: (2010)

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
by: de Koning, H, et al.
Published: (2002)

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.
by: Carlsson, S, et al.
Published: (2012)

European wind variability over 140 yr
by: P. E. Bett, et al.
Published: (2013-04-01)

Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
by: Felipe Lott
Published: (2020-11-01)

Screening for prostate cancer.
by: Carlsson, S, et al.
Published: (2012)

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
by: Zackrisson, B, et al.
Published: (2003)

Screening for prostate cancer: To the editor
by: Carlsson, S, et al.
Published: (2012)

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.
by: Roobol, M, et al.
Published: (2012)

Screening for prostate cancer: early detection or overdetection?
by: Vickers, A, et al.
Published: (2012)

The wheat stripe rust resistance gene YrNAM is Yr10
by: Katherine Dibley, et al.
Published: (2024-04-01)

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.
by: Vickers, A, et al.
Published: (2010)

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
by: Vickers, A, et al.
Published: (2010)

Editorial Comment: Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension
by: Felipe Lott
Published: (2020-07-01)

Ice loss in the Northeastern Tibetan Plateau permafrost as seen by 16 yr of ESA SAR missions
by: Daout, S, et al.
Published: (2020)

Prostate cancer screening in Europe and Asia
by: Kai Zhang, et al.
Published: (2017-04-01)

Editorial Comment: Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
by: Felipe Lott
Published: (2020-09-01)

Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial
by: R. Hietikko, et al.
Published: (2020-07-01)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.
by: Gupta, A, et al.
Published: (2010)

Lead time associated with screening for prostate cancer.
by: Törnblom, M, et al.
Published: (2004)

Erratum: PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section (International Journal of Cancer (2007) 120, (170-174))
by: Khatami, A, et al.
Published: (2007)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
by: Scardino Peter T, et al.
Published: (2008-07-01)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden.
by: Vickers, A, et al.
Published: (2008)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
by: Becker, C, et al.
Published: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
by: Becker, C, et al.
Published: (2003)

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section.
by: Khatami, A, et al.
Published: (2007)

Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam
by: Renée Hogenhout, et al.
Published: (2022-08-01)

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
by: Vickers, A, et al.
Published: (2010)

Fibrosing mediastinitis causing rapidly progressive dyspnea, pulmonary edema and death in a 16 yr old male
by: K. Malagari, et al.
Published: (2004-06-01)

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.
by: Bruun, L, et al.
Published: (2005)

Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.
by: Bergdahl, A, et al.
Published: (2009)

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.
by: Hugosson, J, et al.
Published: (2004)

Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
by: Hugosson, J, et al.
Published: (2003)

Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01)